CC
NBP

Centiva Capital’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Centiva Capital’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,923
Closed -$34.2K – 1992
2023
Q3 		$34.2K Buy
+25,923
New +$56.9K ﹤0.01% 1623

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
EPL
EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Centiva Capital's NBP Position: Q4 2023 in Review

Centiva Capital sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2023, closing a stake of 25,923 shares — an estimated $34.2K sold.

Centiva Capital first reported a position in NBP in Q3 2023 and held it in 1 quarter. The position peaked at $34.2K in Q3 2023. 44 funds tracked by Wall St. Rank hold NBP as of Q4 2023.

  • Centiva Capital reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Centiva Capital sold 25,923 NovaBridge Biosciences American Depositary Shares shares in Q4 2023, an estimated $34.2K.
  • Centiva Capital first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2023 and held it in 1 quarter.
  • Centiva Capital's NovaBridge Biosciences American Depositary Shares position peaked at $34.2K in Q3 2023.
  • 44 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2023.

Based on Centiva Capital's 13F filing for Q4 2023, filed 14 Feb 2024.